JAAD 07/26 Minimally-invasive modalities for non-melanoma skin cancer Part II: Treatment

JAAD 07/26 Minimally invasive modalities for keratinocyte carcinomas Part I: Diagnostics

Keratinocyte carcinoma is the most common cancer in the US, yet biopsy and surgery are not always feasible or desired. This CME activity covers noninvasive diagnostic tools, including dermoscopy, confocal microscopy, and optical coherence tomography, then reviews evidence-based treatment alternatives, from topical and intralesional therapies to photodynamic therapy, for patients who are poor surgical candidates. Build a practical toolkit for diagnosing and managing keratinocyte carcinoma when surgery isn't the first choice.

1 CME

JAAD 06/26 Photodynamic Therapy: Overview and Mechanism of Action

Photodynamic therapy (PDT) has expanded well beyond actinic keratoses, with growing evidence across many dermatologic conditions. This CME activity covers PDT's mechanism of action, photosensitizers, and light sources, then reviews its evidence-based clinical applications, from actinic keratoses and basal cell carcinoma to acne, port wine stains, and rosacea. Build a practical, evidence-based framework for incorporating PDT into dermatologic practice.

1 CME

JAAD 04/26 Frontal Fibrosing Alopecia (FFA) Part I - Diagnosis and Clinical Presentation

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME

JAAD 06/26 Photodynamic Therapy: Clinical Applications in Dermatology

Photodynamic therapy (PDT) has expanded well beyond actinic keratoses, with growing evidence across many dermatologic conditions. This CME activity covers PDT's mechanism of action, photosensitizers, and light sources, then reviews its evidence-based clinical applications, from actinic keratoses and basal cell carcinoma to acne, port wine stains, and rosacea. Build a practical, evidence-based framework for incorporating PDT into dermatologic practice.

1 CME

JAAD 02/26 Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Molecular Profile, Clinical Presentation, and Diagnosis

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME

JAAD 05/26 Part 1 - The Dermatologic Oral Examination and Biopsy: A Guide for Incorporation into Everyday Practice

The oral mucosa falls within dermatology's purview, yet training in its examination remains limited. This CME activity reviews oral anatomy and provides a step-by-step guide to the dermatologic oral exam and biopsy technique, then introduces the Oral Dermatoses Map, organizing key conditions by anatomical site of involvement. Strengthen the ability to examine, diagnose, and manage disorders of the oral cavity in everyday practice.

1 CME

JAAD 12/25 Lentigo Maligna Part I: Epidemiology, Risk Factors, and Diagnosis

Multiple Credits

JAAD 04/26 Frontal Fibrosing Alopecia Part II: Etiopathogenesis and Management

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME

JAAD 02/26 Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of Systemic Therapy, Shortcomings and Future Directions

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME

JAAD 12/25 Lentigo Maligna Part II: Management

Multiple Credits